Endogenex

Plymouth, United States

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

$88.0M raised

Jun 2024

Series C

Top Investors

Longitude CapitalHatteras Venture PartnersLumira VenturesMayo ClinicIntuitive Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Endogenex raised?

Endogenex has raised $88.0M in total funding. The most recent round was Series C. The last funding was announced in June 2024.

Who are Endogenex's investors?

Endogenex's investors include Longitude Capital, Hatteras Venture Partners, Lumira Ventures, Mayo Clinic, Intuitive Ventures.

Where is Endogenex headquartered?

Endogenex is headquartered in Plymouth, United States.

What does Endogenex do?

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

What stage is Endogenex at?

Endogenex is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 25, 2024.

MLA

"Endogenex — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/endogenex. Accessed June 17, 2026.

APA

VCBacked. (2024). Endogenex — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/endogenex

Wikipedia (cite web)

{{cite web |title=Endogenex — Funding & Investors |url=https://www.vcbacked.co/company/endogenex |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 25, 2024.